Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: BDM-2 in Bottle (50 mg - 3600 mg); oral suspension
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Hivih
- Target Recruit Count
- 16
- Registration Number
- NCT03634085
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
News
No news found